[FLASH SALE] Global Database of Stem Cell Therapy Companies, 2026

Description

The world’s only searchable, sortable database of stem cell therapy companies that is publicly available.

This week only, you can claim this database for an unusual $150 off.

Today, there are 371 companies worldwide that are developing stem cell products for therapeutic use in humans to address a diverse range of chronic and acute conditions.

Currently, mesenchymal stem cells (MSCs) and hematopoietic stem cells are the most commonly used stem cell types. However, induced pluripotent stem cells (iPSCs) are also gaining traction, with dozens of companies now forging the path toward iPSC-derived cellular therapeutics.

Other stem cell types, such as neural stem cells and embryonic stem cells, are being used more selectively. Of course, stem cell-derived exosomes have rapidly expanded their therapeutic applications in recent years too.

The rapid growth of stem cell companies is being driven by:

• Accelerated funding for stem cell therapeutics
• Increased interest among pharmaceutical companies in stem cell partnerships
• Expanding interest from investors in stem cell technologies
• Rising numbers of stem cell clinical trials worldwide

Stem Cell Therapy Companies

This comprehensive database of stem cell companies includes all known market competitors who are developing stem cell therapies for use in human patients.

For each entry, it includes the following data points:

• Company Name
• Location (City/State)
• Country
• Website
• Description of Stem Cell Therapy/Technology
• Contact Email
• Company LinkedIn Page

Please note that this is a database of companies which are developing stem cell therapeutics through formal regulatory channels — such as the U.S. FDA, European Medicines Agency (EMA), Chinese NMPA, Japanese PMDA, etc.

Proprietary Insights AI Can Not Provide

As you can imagine, it takes our analysts a vast amount of research to uncover the identities, expertise, and technologies utilized by stem cell companies from across the globe. In addition to diligently searching through hundreds of resources, we utilized translators and crowd-sourced feedback from BioInformant’s partners, clients, and readership.

As you can imagine, the quality of this database would not be possible without the past 19 years of following this industry and developing proprietary datasets (to which AI does not have access).

These insights exist because they are built on nearly two decades of granular tracking, interviews, proprietary datasets, and daily monitoring of the regenerative medicine and advanced therapies landscape, which AI cannot replicate or access.

If you want immediate and actionable insights from a trusted, U.S. based provider that specializes exclusively in cell therapy market insights, then this database is for you.

Access It Immediately

When you claim it below, your product will be delivered instantly as an Excel download. Of course, your investment is backed by a Greater than 100% Money Back Guarantee. If you have questions, please email [email protected] for a quick reply.

Format: Excel File (Delivered Instantly with Purchase)
No. of Companies: 371 Total
Last Updated: April 6, 2026

For a limited time, you can claim it for an unusual $150 off. Remember to act fast, because this offer expires soon and then you’ll have to pay twice the price.